Related Experiment Video
Updated: May 1, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
11.7K
Immunomodulation by the estrogen metabolite 2-methoxyestradiol
Alexandra Stubelius1, Malin C Erlandsson1, Ulrika Islander1
1Centre for Bone and Arthritis Research (CBAR), Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Clinical Immunology (Orlando, Fla.)
|April 3, 2014
Summary
2-methoxyestradiol (2me2) affects the immune system in a dose-dependent manner, with lower doses increasing immune cells and higher doses mimicking 17β-estradiol (E2) effects, impacting drug development.
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- 2-methoxyestradiol (2me2), a metabolite of 17β-estradiol (E2), has shown potential in cancer and inflammation but its immunomodulatory effects are not fully understood.
- Estrogen (E2) is known to modulate the immune system.
Purpose of the Study:
- To investigate the immunomodulatory effects of 2me2 at different concentrations.
- To compare the effects of 2me2 with E2 on immune cells and tissue proliferation.
- To assess the potential of 2me2 as a therapeutic agent.
Main Methods:
- Ovariectomized or sham-operated mice were treated with high (2me2H) and low (2me2L) doses of 2me2, E2, or vehicle.
- Effects on immune cell populations (NK and T-cells) in bone marrow, spleen, and liver were analyzed.
- Uterus proliferation and estrogen response element (ERE) activation were investigated.
Main Results:
- 2me2L significantly increased NK and T-cells in various tissues.
- Both 2me2H and E2 induced uterus proliferation in ovariectomized mice.
- 2me2H and E2 activated EREs, indicating estrogenic activity.
- Immunomodulation by 2me2 was found to be tissue- and concentration-dependent.
Conclusions:
- 2me2 exhibits immunomodulatory properties that are distinct from and also similar to E2, depending on the dose.
- Higher doses of 2me2 can elicit E2-like effects, which is a critical consideration for its clinical development.
- The findings highlight the complex role of 2me2 in immune regulation and tissue response.
Keywords:
17β-Estradiol2-MethoxyestradiolEstrogen response elementsImmune regulationImmune systemUterus proliferationMore Related Videos
Related Concept Videos
01:17Phase II Reactions: Methylation Reactions
915
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
915
01:22Hormonal Regulation of the Menstrual Cycle
2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
01:37Epigenetic Regulation
3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.5K
01:46Epigenetic Regulation
28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
02:07Oogenesis
58.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
58.4K